Search Results - "TANOSAKI, RYUJI"

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors by Hirai, Ikuko, Funakoshi, Takeru, Kamijuku, Hajime, Fukuda, Keitaro, Mori, Mariko, Sakurai, Masatoshi, Koda, Yuya, Kato, Jun, Mori, Takehiko, Watanabe, Naohide, Noji, Shinobu, Yaguchi, Tomonori, Iwata, Takashi, Ohta, Shigeki, Fujita, Tomonobu, Tanosaki, Ryuji, Handa, Makoto, Okamoto, Shinichiro, Amagai, Masayuki, Kawakami, Yutaka

“…To evaluate the feasibility of adoptive cell therapy (ACT) using ex vivo‐expanded tumor‐infiltrating lymphocytes (TILs) in Japanese patients with melanoma who…”
Get full text

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience by Tsubokura, Misato, Adegawa, Yuko, Kojima, Minoru, Tanosaki, Ryuji, Ohtake, Ryuzaburo, Kase, Yuki, Iwashita, Nao, Kasane, Moemi, Nakabayashi, Saori, Takeuchi, Sayaka, Kato, Ken, Boku, Narikazu, Kanemitsu, Yukihide, Okusaka, Takuji, Fujimoto, Hiroyuki, Yonemori, Kan, Ishiki, Hiroto, Kawamura, Kimihiko, Satomi, Eriko, Matsushita, Hiromichi

“…Cell-free and concentrated ascites reinfusion therapy (CART) is a strategy for improving various intractable symptoms due to refractory ascites, including…”
Get full text

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial by OSHITA, CHIE, TAKIKAWA, MASAKO, KUME, AKIKO, MIYATA, HARUO, ASHIZAWA, TADASHI, IIZUKA, AKIRA, KIYOHARA, YOSHIO, YOSHIKAWA, SHUSUKE, TANOSAKI, RYUJI, YAMAZAKI, NAOYA, YAMAMOTO, AKIFUMI, TAKESAKO, KAZUTOH, YAMAGUCHI, KEN, AKIYAMA, YASUTO

“…Metastatic and chemoresistant melanoma can be a good target of immunotherapy because it is an intractable cancer with a very poor prognosis. Previously, we…”
Get full text

Comparison of cryoprotectants in hematopoietic cell infusion–related adverse events by Ikeda, Kazuhiko, Minakawa, Keiji, Yamahara, Kenichi, Yamada‐Fujiwara, Minami, Okuyama, Yoshiki, Fujiwara, Shin‐ichiro, Yamazaki, Rie, Kanamori, Heiwa, Iseki, Tohru, Nagamura‐Inoue, Tokiko, Kameda, Kazuaki, Nagai, Kazuhiro, Fujii, Nobuharu, Ashida, Takashi, Hirose, Asao, Takahashi, Tsutomu, Ohto, Hitoshi, Ueda, Koki, Tanosaki, Ryuji

“…Background The standard cryoprotectant for human cellular products is dimethyl sulfoxide (DMSO), which is associated with hematopoietic cell infusion‐related…”
Get full text

Hematopoietic cell infusion‐related adverse events in pediatric/small recipients in a prospective/multicenter study by Ikeda, Kazuhiko, Ohto, Hitoshi, Yamada‐Fujiwara, Minami, Okuyama, Yoshiki, Fujiwara, Shin‐ichiro, Muroi, Kazuo, Mori, Takehiko, Kasama, Kinuyo, Kanamori, Heiwa, Iseki, Tohru, Nagamura‐Inoue, Tokiko, Kameda, Kazuaki, Kanda, Junya, Nagai, Kazuhiro, Fujii, Nobuharu, Ashida, Takashi, Hirose, Asao, Takahashi, Tsutomu, Minakawa, Keiji, Tanosaki, Ryuji

“…BACKGROUND Hematopoietic cell infusion‐related adverse events (HCI‐AEs) in hematopoietic stem cell transplantations (HSCTs) have been largely attributed to…”
Get full text

Clinical Results of a Massive Blood Transfusion Protocol for Postpartum Hemorrhage in a University Hospital in Japan: A Retrospective Study by Ochiai, Daigo, Abe, Yushi, Yamazaki, Rie, Uemura, Tomoe, Toriumi, Ayako, Matsuhashi, Hiroko, Tanaka, Yuya, Ikenoue, Satoru, Kasuga, Yoshifumi, Tanosaki, Ryuji, Tanaka, Mamoru

“…Background and objectives: Massive postpartum hemorrhage (PPH) is the most common cause of maternal death worldwide. A massive transfusion protocol (MTP) may…”
Get full text

Recent therapeutic strategy for hematologic disorders--hematopoietic stem cell transplantation. Overview by Tanosaki, Ryuji

Get more information

Prospective randomized and crossover comparison of two apheresis machines for peripheral blood stem cell collection: a multicenter study by Ikeda, Kazuhiko, Minakawa, Keiji, Muroi, Kazuo, Fujiwara, Shin-ichiro, Yamada-Fujiwara, Minami, Fujimori, Yoshihiro, Tanosaki, Ryuji, Ohto, Hitoshi

“…BACKGROUND Improving apheresis technology may lead to an efficient and safe peripheral blood stem cell (PBSC) collection. Recently, the Spectra Optia (Optia,…”
Get full text

Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review by Shimada, Naoki, Ohno, Nobuhiro, Tanosaki, Ryuji, Fuji, Shigeo, Suzuki, Yuhko, Yuji, Koichiro, Uchimaru, Kaoru, Tojo, Arinobu

“…A 61-year-old woman with chronic-type adult T-cell leukemia-lymphoma (ATL) had been taking low-dose oral etoposide for progressive lymphocytosis. After taking…”
Get full text

Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study by Kasane, Moemi, Kurosawa, Saiko, Kojima, Minoru, Iwashita, Nao, Kase, Yuki, Tsubokura, Misato, Nakabayashi, Saori, Ikeda, Chiaki, Kawamura, Kimihiko, Matsushita, Hiromichi, Narita, Ryuichi, Fukumoto, Hidetomo, Fujino, Takahiro, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Maruyama, Dai, Ito, Ayumu, Tanaka, Takashi, Inamoto, Yoshihiro, Kim, Sung-Won, Tajima, Kinuko, Tanosaki, Ryuji, Izutsu, Koji, Fukuda, Takahiro

“…In autologous peripheral blood stem cell harvest (APBSCH), CD34-positive cells have been measured to assess the numbers of hematopoietic stem cells, but…”
Get full text

Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood–ocular barrier by Hirano, Mitsuhito, Ohno, Nobuhiro, Tanosaki, Ryuji, Mochizuki, Manabu, Ohno-Matsui, Kyoko, Uchimaru, Kaoru, Tojo, Arinobu, Kamoi, Koju

“…Adult T-cell leukemia–lymphoma (ATL), a rare lymphoid malignancy with a high mortality rate, is caused by the human T-cell leukemia virus type 1. Due to its…”
Get full text

Hematopoietic stem cell transplantation for hematologic disorders by Tanosaki, Ryuji

“…There have been a great progress in hematopoietic stem cell transplantation (SCT) for hematologic malignancies in various aspects including stem cell sources,…”
Get more information

Clinical Outcomes after Allogeneic Stem Cell Transplantation for Adult Lymphoblastic Lymphoma by Makita, Shinichi, Fuji, Shigeo, Takano, Kuniko, Tanaka, Takashi, Inoue, Yoshitaka, Ito, Reiko, Ito, Ayumu, Hayashi, Yoshiki, Tajima, Kinuko, Okinaka, Keiji, Kurosawa, Saiko, Kim, Sung-Won, Yamashita, Takuya, Tanosaki, Ryuji, Tobinai, Kensei, Fukuda, Takahiro

“…Lymphoblastic lymphoma (LBL) is a rare subtype of non-Hodgkin lymphoma. There are limited reports on allogeneic stem cell transplantation (allo-SCT) in…”
Get full text

Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation by Munakata, Wataru, Nomoto, Junko, Takahashi, Noriko, Taniguchi, Hirokazu, Maeshima, Akiko Miyagi, Asamura, Hisao, Tanosaki, Ryuji, Heike, Yuji, Fukuda, Takahiro, Tobinai, Kensei, Kobayashi, Yukio

“…Secondary cancers developing after allogeneic hematopoietic stem cell transplantation generally originate from recipient-derived cells. In this study, we…”
Get full text

Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation by Tanaka, Takashi, Inamoto, Yoshihiro, Yamashita, Takuya, Fuji, Shigeo, Okinaka, Keiji, Kurosawa, Saiko, Kim, Sung-Won, Tanosaki, Ryuji, Fukuda, Takahiro

“…Abstract Persistent thrombocytopenia is a common complication after allogeneic hematopoietic cell transplantation (HCT). Eltrombopag is an oral thrombopoietin…”
Get full text

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome by Imataki, Osamu, Kamioka, Takeshi, Fukuda, Takashi, Tanosaki, Ryuji, Takaue, Yoichi

“…Goals of work Allogeneic stem cell transplantation with a reduced-intensity regimen (RIST) has been evaluated mostly in terms of its clinical benefit, and the…”
Get full text

Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma by OKAMURA, Jun, UIKE, Naokuni, UTSUNOMIYA, Atae, TANOSAKI, Ryuji

“…Adult T-cell leukemia/lymphoma (ATLL) develops in elderly individuals who have been infected with human T-cell leukemia virus type 1 (HTLV-1), and the…”
Get full text

Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients by Yokoyama, Hiroki, Mori, Shin-ichiro, Kobayashi, Yukio, Kurosawa, Saiko, Saito, Bungo, Fuji, Shigeo, Maruyama, Dai, Azuma, Teruhisa, Kim, Sung-Won, Watanabe, Takashi, Tanosaki, Ryuji, Tobinai, Kensei, Takaue, Yoichi, Fukuda, Takahiro

“…The prognosis of therapy-related myelodysplastic syndrome and acute leukemia (t-MDS/AL) remains poor. We retrospectively analyzed the data of 47 patients (31…”
Get full text

Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy by Jo, Tomoyasu, Henzan, Tomoko, Tomizawa, Daisuke, Yoshihara, Satoru, Kahata, Kaoru, Yamada-Fujiwara, Minami, Okuyama, Yoshiki, Shiba, Norio, Fujii, Keiko, Umezawa, Yoshihiro, Yamazaki, Rie, Takeda, Wataru, Hanajiri, Ryo, Fukushima, Kentaro, Mimura, Naoya, Ikemoto, Junko, Iwaki, Keita, Yonetani, Noboru, Fujiwara, Shin-Ichiro, Ri, Masaki, Nagamura-Inoue, Tokiko, Tanosaki, Ryuji, Arai, Yasuyuki

“…The frequency of the manufacturing failure of chimeric antigen receptor (CAR)-T cell therapy in clinical practice is unknown. To clarify the current state of…”
Get more information

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level by Uike, Naokuni, Tanosaki, Ryuji, Utsunomiya, Atae, Choi, Ilseung, Okamura, Jun

Get full text